CTBP1-AS

Across TCGA pan-cancer cohorts, CTBP1-AS RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of CTBP1-AS’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CTBP1-AS RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CTBP1-AS is over-expressed in tumor, although a few such as BRCA and THCA show the opposite, repressed pattern.

KIRC, LIHC, and BRCA are the cancer types where CTBP1-AS tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CTBP1-AS RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.206	<.001	8	view →
LIHC	Female	All	+0.288	<.001	7	view →
BRCA	Female	All	−0.245	<.001	6	view →
STAD	All	All	+0.435	.004	5	view →
COAD	Female	All	+0.362	.004	5	view →
KICH	All	II,III,IV	+0.354	.001	5	view →
THCA	All	All	−0.199	.010	4	view →
CHOL	All	All	+1.142	<.001	3	view →
PRAD	All	All	+1.297	<.001	2	view →
KIRP	All	IV	+0.602	.028	2	view →
LUSC	All	All	−0.258	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

CTBP1-AS–KIRC

Open the KIRC breakdown →